 Momenta Pharmaceuticals NASDAQ:MNTA had its target price upped by analysts at SunTrust Banks from 50.00 to 57.00 in a report issued on Wednesday, The Fly reports. SunTrust Banks price objective would suggest a potential upside of 55.19 from the companys current price. Other equities analysts also recently issued reports about the stock. Goldman Sachs Group ... 